In support of this view, YAP with a mutated and defective C-terminal phosphodegron and 14–3-3 binding site, but not YAP fused to an NLS, was sufficient to induce brain tumors in mice (Szulzewsky et al. 2020). This evidence concerns the gene YAP1 and brain neoplasm.